Trials / Completed
CompletedNCT00195481
Study Evaluating Sirolimus in Kidney Transplant Recipients in India
A Post Marketing Surveillance Looking at Safety of Rapamune (Sirolimus) in Indian Population Undergoing de Novo Renal Transplantation.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (planned)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
To determine the safety of sirolimus tablets in renal allograft recipients in a postmarketing surveillance setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rapamune |
Timeline
- Start date
- 2004-04-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2005-09-19
- Last updated
- 2007-12-28
Locations
5 sites across 1 country: India
Source: ClinicalTrials.gov record NCT00195481. Inclusion in this directory is not an endorsement.